McGill Alert / Alerte de McGill

Updated: Mon, 07/15/2024 - 16:07

Gradual reopening continues on downtown campus. See Campus Public Safety website for details.

La réouverture graduelle du campus du centre-ville se poursuit. Complément d'information : Direction de la protection et de la prévention.

Adil Harroud, MD

Adil Harroud, MD
Hospital title: 
Group Co-Leader, Neuroimmunological Diseases Research Group
Location: 
Multiple Sclerosis Programme
Biography: 

Dr. Adil Harroud is a neurologist specializing in multiple sclerosis (MS) and neuroimmunology. His research centers on understanding the mechanisms that underlie MS susceptibility and progression, with a focus on genetics. By identifying genetic and environmental causes of multiple sclerosis, Dr. Harroud aims to identify interventions that can prevent MS and novel pathways for treatment of MS progression. He has contributed to the identification of the first genetic modifiers of disease severity in MS. His research combines genomics, bioinformatics and epidemiology in large international cohorts and biobanks.

Dr. Harroud holds a medical degree from Université de Montréal and completed his neurology residency at McGill University. He then completed a research fellowship in MS genetics at the University of California, San Francisco.

Research areas: 
Neuroimmunological Diseases

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

Facebook instagram x, formerly known as twitter linkedIn youtube

Back to top